These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 29850528

  • 21. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.
    Li G, Wang K, Wang J, Qin S, Sun X, Ren H.
    J Cell Biochem; 2019 Jun; 120(6):10587-10595. PubMed ID: 30816573
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z, Duan C.
    Mol Cancer; 2015 Apr 01; 14():73. PubMed ID: 25889562
    [Abstract] [Full Text] [Related]

  • 23. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.
    Eur J Cancer; 2014 Sep 01; 50(13):2336-50. PubMed ID: 25001183
    [Abstract] [Full Text] [Related]

  • 24. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ, Li G, Luo QS, Li HM.
    IUBMB Life; 2017 Nov 01; 69(11):841-849. PubMed ID: 28940895
    [Abstract] [Full Text] [Related]

  • 25. miR-155-5p and miR-760 mediate radiation therapy suppressed malignancy of non-small cell lung cancer cells.
    Zhu L, Xue F, Cui Y, Liu S, Li G, Li J, Guan B, Zeng H, Bian W, Yang C, Zhao C.
    Biofactors; 2019 May 01; 45(3):393-400. PubMed ID: 30901121
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M, Wu Z, Chen J.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):649-55. PubMed ID: 27495872
    [Abstract] [Full Text] [Related]

  • 27. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
    Chen X, Chen S, Hang W, Huang H, Ma H.
    Biomed Pharmacother; 2014 Jun 16; 68(5):589-95. PubMed ID: 24835695
    [Abstract] [Full Text] [Related]

  • 28. Transcriptional activation of miR-320a by ATF2, ELK1 and YY1 induces cancer cell apoptosis under ionizing radiation conditions.
    Hu Z, Tie Y, Lv G, Zhu J, Fu H, Zheng X.
    Int J Oncol; 2018 Oct 16; 53(4):1691-1702. PubMed ID: 30066913
    [Abstract] [Full Text] [Related]

  • 29. MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.
    Shen YY, Cui JY, Yuan J, Wang X.
    Eur Rev Med Pharmacol Sci; 2018 Sep 16; 22(17):5554-5561. PubMed ID: 30229828
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C.
    J Exp Clin Cancer Res; 2016 May 10; 35():76. PubMed ID: 27164951
    [Abstract] [Full Text] [Related]

  • 31. Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase.
    Lee HC, Her NG, Kang D, Jung SH, Shin J, Lee M, Bae IH, Kim YN, Park HJ, Ko YG, Lee JS.
    Cell Death Dis; 2017 Mar 23; 8(3):e2693. PubMed ID: 28333152
    [Abstract] [Full Text] [Related]

  • 32. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
    Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan S, Cai H, Luo Q, Lv Z, Fan L.
    Oncotarget; 2016 Mar 15; 7(11):13139-52. PubMed ID: 26909612
    [Abstract] [Full Text] [Related]

  • 33. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
    Dao R, Wudu M, Hui L, Jiang J, Xu Y, Ren H, Qiu X.
    Pathol Res Pract; 2020 Mar 15; 216(3):152823. PubMed ID: 31983569
    [Abstract] [Full Text] [Related]

  • 34. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R, Dong HX, Zeng J, Pan J, Jin XY.
    J Cell Physiol; 2018 Sep 15; 233(9):7447-7456. PubMed ID: 29663359
    [Abstract] [Full Text] [Related]

  • 35. Long Noncoding RNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity by Suppressing miR-135b Expression in Non-Small Cell Lung Cancer.
    Xue Y, Ni T, Jiang Y, Li Y.
    Oncol Res; 2017 Sep 21; 25(8):1305-1316. PubMed ID: 28117028
    [Abstract] [Full Text] [Related]

  • 36. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J, Zhang Y, Shen W, Fu R, Ding Z, Zhen Y, Wan Y.
    Biomed Pharmacother; 2019 Sep 21; 117():109058. PubMed ID: 31176168
    [Abstract] [Full Text] [Related]

  • 37. MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.
    Wen H, Liu Z, Tang J, Bu L.
    Aging (Albany NY); 2021 Sep 09; 13(17):21435-21450. PubMed ID: 34500436
    [Abstract] [Full Text] [Related]

  • 38. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis.
    Du R, Jiang F, Yin Y, Xu J, Li X, Hu L, Wang X.
    Int J Immunopathol Pharmacol; 2021 Sep 09; 35():2058738420966087. PubMed ID: 33583218
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W, Hang M, Yuan CY, Wu FL, Chen SB, Xue K.
    Int J Clin Exp Pathol; 2015 Sep 09; 8(4):3864-70. PubMed ID: 26097570
    [Abstract] [Full Text] [Related]

  • 40. miR-339-5p Increases Radiosensitivity of Lung Cancer Cells by Targeting Phosphatases of Regenerating Liver-1 (PRL-1).
    Wang J, Jiang M, Xia S.
    Med Sci Monit; 2018 Nov 21; 24():8408-8416. PubMed ID: 30462625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.